ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2025
Exploring chemical constituents and anti-inflammatory mechanisms of Semiaquilegiae Radix via an integrated strategy combining UHPLC-Q-TOF-MS analysis, network pharmacology and molecular docking.
Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrated computational screen and validation of thalidomide-based PROTACs targeting SARS-CoV-2 main protease.RSC medicinal chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Semiaquilegiae Radix demonstrates significant anti-inflammatory potential. However, comprehensive investigations into its anti-inflammatory effects remain sparse. This study seeks to systematically explore the chemical composition of Semiaquilegiae Radix and its underlying anti-inflammatory mechanisms utilizing Ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF-MS/MS), network pharmacology, and molecular docking techniques. Initially, the chemical constituents of Semiaquilegiae Radix were identified and characterized via UHPLC-Q-TOF-MS/MS. Subsequently, the relevant targets were predicted and screened through databases such as PharmMapper and SwissTargetPrediction, in conjunction with protein-protein interaction (PPI) network analysis. Next, Gene Ontology (GO) and Kyoto Encyclopaedia of Genes and Genome (KEGG) enrichment analyses were performed using the Metascape platform. Eventually, molecular docking was carried out via AutoDock Vina and visualized results with PyMOL. From Semiaquilegiae Radix, 19 active compounds were identified, 18 showing activity against inflammation-related targets. 510 drug targets were identified, 188 of which intersected with inflammation-related targets and PPI network analysis pinpointed six core potential targets. These overlapping targets are involved in several critical signaling pathways, including the AGE-RAGE signaling pathway in diabetic complications and pathways related to lipid metabolism and atherosclerosis. Molecular docking showed the primary seven active compounds can effectively bind to key targets. This study elucidates the chemical constituents of Semiaquilegiae Radix and highlights its multi-compound, multi-target, and multi-pathway mechanisms of action against inflammation. This research method provides a robust theoretical foundation for further experimental validation and the development of novel anti-inflammatory therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.